November ANDA Approvals
This article was originally published in Pharmaceutical Approvals Monthly
Full and tentative generic drug approvals from FDA.
You may also be interested in...
At Repro-Med, James Beck has been replaced by Linda Tharby as CEO, and more.
Norway’s Pre Diagnostics uses the intracellular approach to neurodegenerative disease diagnosis. It believes its technology will open up a world of precision medicine for Alzheimer’s disease patients.
Coronavirus Notebook: New EMA Review To Contextualize Blood Clot Risk From AZ Jab, EU Gets Earlier Access To More Pfizer Vaccines
Denmark has stopped using the AstraZeneca vaccine completely, while the Canadian regulator is not recommending restrictions in any specific populations. Can a new EMA review provide better context to guide the vaccine’s use in different age groups and gender?